Total planned funding: $498,872,283
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $151,138,625 |
Zambia | $54,361,841 |
South Africa | $52,897,269 |
Mozambique | $48,298,831 |
Asia Regional Program | $35,475,616 |
Vietnam | $21,579,907 |
Kenya | $17,042,564 |
West Africa Region | $13,460,980 |
Tanzania | $10,022,881 |
Zimbabwe | $9,054,888 |
Botswana | $8,646,354 |
Democratic Republic of the Congo | $8,280,260 |
Dominican Republic | $7,751,779 |
Burundi | $7,625,625 |
Ethiopia | $6,495,568 |
Papua New Guinea | $6,494,909 |
enumerations.Philippines | $6,341,584 |
Malawi | $4,488,600 |
Lesotho | $3,642,229 |
Côte d'Ivoire | $3,588,453 |
Eswatini | $3,580,500 |
Uganda | $3,477,378 |
Rwanda | $3,401,414 |
Ghana | $2,750,000 |
Angola | $2,250,000 |
South Sudan | $1,700,000 |
Namibia | $1,660,293 |
India | $1,422,700 |
Haiti | $827,217 |
Western Hemisphere Region | $709,018 |
Indonesia | $405,000 |
Caribbean Region | $0 |
Organizational Types
NGO | $498,872,283 |
Program Areas
Treatment | $145,509,198 |
Care | $144,740,371 |
Prevention | $115,925,008 |
Testing | $49,181,110 |
Governance and Systems | $43,516,596 |
Budget Codes
HTXS: Treatment: Adult Treatment | $127,170,679 |
HKID: Care: Orphans and Vulnerable Children | $66,298,510 |
HBHC: Care: Adult Care and Support | $58,555,526 |
HVCT: Testing: HIV Testing and Counseling | $49,181,110 |
HVOP: Sexual Prevention: Other Sexual Prevention | $43,782,474 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $41,424,254 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,388,206 |
OHSS: Health Systems Strengthening | $15,544,318 |
HLAB: Laboratory Infrastructure | $15,404,179 |
PDTX: Treatment: Pediatric Treatment | $13,256,405 |
HVSI: Strategic Information | $12,568,099 |
HVTB: Care: TB/HIV | $10,983,498 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,922,268 |
PDCS: Care: Pediatric Care and Support | $8,902,837 |
HTXD: Treatment: ARV Drugs | $5,082,114 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,923,984 |
HMIN: Biomedical Prevention: Injection Safety | $398,793 |
HMBL: Biomedical Prevention: Blood Safety | $85,029 |
Top Partner Programs
FHI 360:
$498,872,283
View countries